Cone beam CT pulmonary angiography in balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension during the program initiation period

dc.contributor.authorPáez Carpio, Alfredo
dc.contributor.authorZarco Contreras, Federico Xavier
dc.contributor.authorSerrano Alcalá, Elena
dc.contributor.authorVollmer, Ivan
dc.contributor.authorPuig, José
dc.contributor.authorBarberà i Mir, Joan Albert
dc.contributor.authorGomez, F. M.
dc.contributor.authorBlanco Vich, Isabel
dc.date.accessioned2025-06-04T08:32:22Z
dc.date.available2025-06-04T08:32:22Z
dc.date.issued2025-02-13
dc.date.updated2025-05-29T08:09:21Z
dc.description.abstractAIM Cone beam CT pulmonary angiography (CBCT-PA) has proven to be a valuable technique during balloon pulmonary angioplasty (BPA) for chronic thromboembolic pulmonary hypertension (CTEPH) in established centres. This study aimed to demonstrate the safety and efficacy of CBCT-PA-guided BPA for CTEPH during the initial period of a BPA program. CBCT-PA improves procedural accuracy by visualising distal thromboembolic lesions and providing real-time guidance, which is critical during program initiation. MATERIALS AND METHODS This single-centre, single-arm study prospectively evaluated patients with CTEPH undergoing BPA from 2017 to 2022. Outcomes of interest included pre-BPA and post-BPA 6-minute walking distance, New York Heart Association Functional Classification (NYHA-FC), mean pulmonary artery pressure (mPAP), pulmonary vascular resistance (PVR), N-terminal pro B-type natriuretic peptide (NT-proBNP), and BPA-related adverse events (AEs). Statistical analysis compared pre-BPA and post-BPA results. CBCT-PA was used for three-dimensional (3D) vascular mapping and precise lesion targeting. RESULTS Ninety BPA sessions were performed on 19 patients under CBCT-PA guidance. Significant improvements were observed in mPAP (37.0 mmHg [interquartile range (IQR): 28.0-46.0] vs 25.5 [IQR: 22.8-31.5]; P<0.001), PVR (5.5 Wood units [IQR: 3.4-8.5] vs 3.3 [IQR: 2.7-4.6]; P < 0.001), NYHA-FC I-II rate (8 [42%] vs 18 [94%]; P = 0.04), and NT-proBNP (165 pg/mL [IQR: 82-1146] vs 127.0 [IQR: 57-216]; P = 0.014). Overall AE rate was 14.4%, and major AE rate was 7.7% (all Cardiovascular and Interventional Radiology Society of Europe [CIRSE] grade 3). The haemoptysis rate was 4.4%. No periprocedural deaths were reported. CONCLUSION BPA performed under CBCT-PA guidance appeared to be an effective and safe approach in the program's initial period, helping achieving similar results as established centres.
dc.format.extent10 p.
dc.format.mimetypeapplication/pdf
dc.identifier.issn0009-9260
dc.identifier.pmid40058193
dc.identifier.urihttps://hdl.handle.net/2445/221363
dc.language.isoeng
dc.publisherElsevier BV
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1016/j.crad.2025.106847
dc.relation.ispartofClinical Radiology, 2025, vol. 84
dc.relation.urihttps://doi.org/10.1016/j.crad.2025.106847
dc.rightscc-by (c) Páez Carpio et al., 2025
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.sourceArticles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
dc.subject.classificationHipertensió pulmonar
dc.subject.classificationAngiografia
dc.subject.otherPulmonary hypertension
dc.subject.otherAngiography
dc.titleCone beam CT pulmonary angiography in balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension during the program initiation period
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
PIIS0009926025000522.pdf
Mida:
1.62 MB
Format:
Adobe Portable Document Format